10.15 USD
+0.02 (+0.2%)
10.17 USD
+0.02 (+0.2%)
ChartMill assigns a Buy % Consensus number of 50% to ITOS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.56. This target is 4% above the current price.
ITOS was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about ITOS.
In the previous month the buy percentage consensus was at a similar level.
ITOS was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-28 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-05-28 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-05-14 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-05-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-05-13 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-04-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | Wells Fargo | Initiate | Overweight |
| 2024-08-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-16 | Wedbush | Maintains | Outperform |
| 2023-03-16 | JP Morgan | Maintains | Overweight |
| 2022-05-13 | SVB Leerink | Maintains | Outperform |
| 2021-12-13 | HC Wainwright & Co. | Maintains | Buy |
ITEOS THERAPEUTICS INC / ITOS FAQ
What is the price target for ITOS stock?
10 analysts have analysed ITOS and the average price target is 10.56 USD. This implies a price increase of 4% is expected in the next year compared to the current price of 10.15.
What is the consensus rating for ITEOS THERAPEUTICS INC (ITOS) stock?
The consensus rating for ITEOS THERAPEUTICS INC (ITOS) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for ITOS stock?
The number of analysts covering ITEOS THERAPEUTICS INC (ITOS) is 10.